Mark Scapens
Directeur/Bestuurslid bij CANNASOUTH LIMITED
Profiel
Mark Scapens is a professional who currently holds two positions as a Non-Executive Director at Cannasouth Ltd.
and as a Director at Eqalis Pharmaceuticals Ltd.
He previously worked as a Non-Executive Director at Aspire2 Group Ltd.
Actieve functies van Mark Scapens
| Bedrijven | Functie | Begin |
|---|---|---|
| CANNASOUTH LIMITED | Directeur/Bestuurslid | - |
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Scapens
| Bedrijven | Functie | Einde |
|---|---|---|
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aspire2 Group Ltd.
Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Commercial Services |
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
